Clinical Pharmacist’s Intervention to Improve Medication Titration for Heart Failure: First Experience from Sudan

Kannan O Ahmed,1 Imad Taj Eldin,2 Mirghani Yousif,1 Ahmed A Albarraq,3 Bashir A Yousef,4 Nasrein Ahmed,5 Anas Babiker6 1Department of Clinical Pharmacy, Faculty of Pharmacy, University of Gezira, Wad Medani, Sudan; 2Department of Pharmacology, Faculty of Pharmacy, University of Gezira, Wad Medani, S...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ahmed KO, Taj Eldin I, Yousif M, Albarraq AA, Yousef BA, Ahmed N, Babiker A
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2021
Materias:
Acceso en línea:https://doaj.org/article/a16b7b64d2b143f9aa0afca2851079b2
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:a16b7b64d2b143f9aa0afca2851079b2
record_format dspace
spelling oai:doaj.org-article:a16b7b64d2b143f9aa0afca2851079b22021-11-11T18:22:26ZClinical Pharmacist’s Intervention to Improve Medication Titration for Heart Failure: First Experience from Sudan2230-5254https://doaj.org/article/a16b7b64d2b143f9aa0afca2851079b22021-11-01T00:00:00Zhttps://www.dovepress.com/clinical-pharmacists-intervention-to-improve-medication-titration-for--peer-reviewed-fulltext-article-IPRPhttps://doaj.org/toc/2230-5254Kannan O Ahmed,1 Imad Taj Eldin,2 Mirghani Yousif,1 Ahmed A Albarraq,3 Bashir A Yousef,4 Nasrein Ahmed,5 Anas Babiker6 1Department of Clinical Pharmacy, Faculty of Pharmacy, University of Gezira, Wad Medani, Sudan; 2Department of Pharmacology, Faculty of Pharmacy, University of Gezira, Wad Medani, Sudan; 3Pharmacy Practice Research Unit, Department of Clinical Pharmacy, College of Pharmacy, Jazan University, Jazan, Saudi Arabia; 4Department of Pharmacology, Faculty of Pharmacy, University of Khartoum, Khartoum, Sudan; 5Department of Cardiology, Ahmed Gasim Cardiac Surgery and Renal Transplantation Centre, Khartoum, Sudan; 6Department of Cardiology, Royal Care International Hospital, Khartoum, SudanCorrespondence: Kannan O AhmedDepartment of Clinical Pharmacy, Faculty of Pharmacy, University of Gezira, Hospital Street No. 1, Wad Medani, 21112, SudanTel +249 121860001Fax +249 511861180Email omerkannan@gmail.comBackground: Medications known to improve outcomes in heart failure (HF) are either not prescribed or prescribed at sub-therapeutic doses. The addition of clinical pharmacists to the HF team positively impacts optimizing prognostic medications for a patient with HF with reduced ejection fraction (HFrEF).Objective: To assess the intervention of the clinical pharmacist as part of the multidisciplinary (MD) team in up-titration to achieve target doses of key therapeutic agents for HFrEF.Methods: This was a prospective one group pretest-posttest interventional study; a comparison of the target dose achievement of key therapeutic agents for HFrEF was performed before and after clinical pharmacist interventions.Results: Out of 110 HFrEF patients, 57.3% were males, and the mean age of patients was 55.8 years (SD 12.6). Cardiomyopathy was the leading cause of HF. At baseline, 86% were on angiotensin-converting enzyme inhibitors/angiotensin receptor blockers/angiotensin receptor-neprilysin inhibitors (ACEIs/ARBs/ARNi) and 93.6% on beta blockers (BBs). At the end of study, the proportion of patients achieved the target dose was significantly increased (0 vs 77.4%, 6.8 vs 85.4%, and 0 vs 55.6%) for ACEIs, ARBs and ARNi, respectively, and (8.6% vs 66.1%; P = 0.001) for BBs. Moreover, the up-titration process was associated with significant improvement in most clinical as ejection fraction and New York Heart Association (NYHA) scale and laboratory characteristics.Conclusion: As a part of the MD team in the outpatient HF clinic, the clinical pharmacists increased the percentage of HFrEF patients achieving the target or maximal doses of key therapeutic agents and improving clinical and laboratory parameters.Keywords: clinical pharmacist, intervention, heart failure, medications titration, SudanAhmed KOTaj Eldin IYousif MAlbarraq AAYousef BAAhmed NBabiker ADove Medical Pressarticleclinical pharmacistinterventionheart failuremedications titrationsudanPharmacy and materia medicaRS1-441ENIntegrated Pharmacy Research and Practice, Vol Volume 10, Pp 135-143 (2021)
institution DOAJ
collection DOAJ
language EN
topic clinical pharmacist
intervention
heart failure
medications titration
sudan
Pharmacy and materia medica
RS1-441
spellingShingle clinical pharmacist
intervention
heart failure
medications titration
sudan
Pharmacy and materia medica
RS1-441
Ahmed KO
Taj Eldin I
Yousif M
Albarraq AA
Yousef BA
Ahmed N
Babiker A
Clinical Pharmacist’s Intervention to Improve Medication Titration for Heart Failure: First Experience from Sudan
description Kannan O Ahmed,1 Imad Taj Eldin,2 Mirghani Yousif,1 Ahmed A Albarraq,3 Bashir A Yousef,4 Nasrein Ahmed,5 Anas Babiker6 1Department of Clinical Pharmacy, Faculty of Pharmacy, University of Gezira, Wad Medani, Sudan; 2Department of Pharmacology, Faculty of Pharmacy, University of Gezira, Wad Medani, Sudan; 3Pharmacy Practice Research Unit, Department of Clinical Pharmacy, College of Pharmacy, Jazan University, Jazan, Saudi Arabia; 4Department of Pharmacology, Faculty of Pharmacy, University of Khartoum, Khartoum, Sudan; 5Department of Cardiology, Ahmed Gasim Cardiac Surgery and Renal Transplantation Centre, Khartoum, Sudan; 6Department of Cardiology, Royal Care International Hospital, Khartoum, SudanCorrespondence: Kannan O AhmedDepartment of Clinical Pharmacy, Faculty of Pharmacy, University of Gezira, Hospital Street No. 1, Wad Medani, 21112, SudanTel +249 121860001Fax +249 511861180Email omerkannan@gmail.comBackground: Medications known to improve outcomes in heart failure (HF) are either not prescribed or prescribed at sub-therapeutic doses. The addition of clinical pharmacists to the HF team positively impacts optimizing prognostic medications for a patient with HF with reduced ejection fraction (HFrEF).Objective: To assess the intervention of the clinical pharmacist as part of the multidisciplinary (MD) team in up-titration to achieve target doses of key therapeutic agents for HFrEF.Methods: This was a prospective one group pretest-posttest interventional study; a comparison of the target dose achievement of key therapeutic agents for HFrEF was performed before and after clinical pharmacist interventions.Results: Out of 110 HFrEF patients, 57.3% were males, and the mean age of patients was 55.8 years (SD 12.6). Cardiomyopathy was the leading cause of HF. At baseline, 86% were on angiotensin-converting enzyme inhibitors/angiotensin receptor blockers/angiotensin receptor-neprilysin inhibitors (ACEIs/ARBs/ARNi) and 93.6% on beta blockers (BBs). At the end of study, the proportion of patients achieved the target dose was significantly increased (0 vs 77.4%, 6.8 vs 85.4%, and 0 vs 55.6%) for ACEIs, ARBs and ARNi, respectively, and (8.6% vs 66.1%; P = 0.001) for BBs. Moreover, the up-titration process was associated with significant improvement in most clinical as ejection fraction and New York Heart Association (NYHA) scale and laboratory characteristics.Conclusion: As a part of the MD team in the outpatient HF clinic, the clinical pharmacists increased the percentage of HFrEF patients achieving the target or maximal doses of key therapeutic agents and improving clinical and laboratory parameters.Keywords: clinical pharmacist, intervention, heart failure, medications titration, Sudan
format article
author Ahmed KO
Taj Eldin I
Yousif M
Albarraq AA
Yousef BA
Ahmed N
Babiker A
author_facet Ahmed KO
Taj Eldin I
Yousif M
Albarraq AA
Yousef BA
Ahmed N
Babiker A
author_sort Ahmed KO
title Clinical Pharmacist’s Intervention to Improve Medication Titration for Heart Failure: First Experience from Sudan
title_short Clinical Pharmacist’s Intervention to Improve Medication Titration for Heart Failure: First Experience from Sudan
title_full Clinical Pharmacist’s Intervention to Improve Medication Titration for Heart Failure: First Experience from Sudan
title_fullStr Clinical Pharmacist’s Intervention to Improve Medication Titration for Heart Failure: First Experience from Sudan
title_full_unstemmed Clinical Pharmacist’s Intervention to Improve Medication Titration for Heart Failure: First Experience from Sudan
title_sort clinical pharmacist’s intervention to improve medication titration for heart failure: first experience from sudan
publisher Dove Medical Press
publishDate 2021
url https://doaj.org/article/a16b7b64d2b143f9aa0afca2851079b2
work_keys_str_mv AT ahmedko clinicalpharmacistrsquosinterventiontoimprovemedicationtitrationforheartfailurefirstexperiencefromsudan
AT tajeldini clinicalpharmacistrsquosinterventiontoimprovemedicationtitrationforheartfailurefirstexperiencefromsudan
AT yousifm clinicalpharmacistrsquosinterventiontoimprovemedicationtitrationforheartfailurefirstexperiencefromsudan
AT albarraqaa clinicalpharmacistrsquosinterventiontoimprovemedicationtitrationforheartfailurefirstexperiencefromsudan
AT yousefba clinicalpharmacistrsquosinterventiontoimprovemedicationtitrationforheartfailurefirstexperiencefromsudan
AT ahmedn clinicalpharmacistrsquosinterventiontoimprovemedicationtitrationforheartfailurefirstexperiencefromsudan
AT babikera clinicalpharmacistrsquosinterventiontoimprovemedicationtitrationforheartfailurefirstexperiencefromsudan
_version_ 1718431840782516224